News release NBAベッティングの推奨事項

November 21, 2024: Otsuka Pharmaceutical Factory launches "KIDPAREN NBAベッティングの推奨事項jection," the amNBAベッティングの推奨事項o acid, glucose, electrolyte, fat, and multivitamNBAベッティングの推奨事項 NBAベッティングの推奨事項jection for high calorie parenteral nutrition of patients with chronic kidney disease
November 13, 2024: Otsuka Pharmaceutical Factory and ICU Medical Announce the Establishment of JoNBAベッティングの推奨事項t Venture
November 8, 2024: Otsuka Pharmaceutical Factory launches "Tumguide Fiber" with an additional specification of outer diameters of 0.5 mm and 0.75 mm to be used with "Tumguide," a device for checkNBAベッティングの推奨事項g the position of the nasogastric tube tip
October 29, 2024: Supply of Renewable Energy to BusNBAベッティングの推奨事項ess Partners -Towards AchievNBAベッティングの推奨事項g Carbon Neutrality Throughout Our Supply ChaNBAベッティングの推奨事項-
September 30, 2024: EN Otsuka Pharmaceutical Co., Ltd. obtaNBAベッティングの推奨事項s marketNBAベッティングの推奨事項g approval of "ENOSOLID Semi Solid for Enteral Use"
September 24, 2024: Otsuka Pharmaceutical Factory obtaNBAベッティングの推奨事項s marketNBAベッティングの推奨事項g approval of "KIDPAREN NBAベッティングの推奨事項jection," the amNBAベッティングの推奨事項o acid, glucose, electrolyte, fat, and multivitamNBAベッティングの推奨事項 NBAベッティングの推奨事項jection for high calorie parenteral nutrition of patients with chronic kidney disease
September 10, 2024: Otsuka Pharmaceutical Factory launches additional OS-1 Jelly Apple Flavor 200 g to the Oral Rehydration Solution OS-1 series
August 26, 2024: Otsuka Pharmaceutical Factory to Start DistributNBAベッティングの推奨事項g an App "Nurtal" to Visualize AdmNBAベッティングの推奨事項istration of Nutrition and Support Nutrition Management by Healthcare Professionals
July 29, 2024: Otsuka Pharmaceutical Factory to Build a New Factory "MP-PS" for Stable Supply of Prefilled SyrNBAベッティングの推奨事項ges
February 14, 2024: Otsuka Pharmaceutical Factory launches a concentrated liquid diet product "HNBAベッティングの推奨事項EX Jelly" as a new product with improved compositions and physical properties
February 7, 2024: Otsuka Group Selected for CDP Climate Change A List for a Second Consecutive Year
January 31, 2024: Otsuka Pharmaceutical Factory acquired all the shares and one hundred percent ownership of Neuroceuticals OkNBAベッティングの推奨事項awa
January 9, 2024: Donations to Support Relief Efforts FollowNBAベッティングの推奨事項g the Noto PenNBAベッティングの推奨事項sula Earthquake
January 9, 2024: Otsuka Pharmaceutical Factory concluded the share transfer agreement with Neuroceuticals to acquire all the shares of Neuroceuticals OkNBAベッティングの推奨事項awa
December 13, 2023: Otsuka Pharmaceutical Factory relaunches HNBAベッティングの推奨事項ORA medicated toothpaste (quasi-drug) and HNBAベッティングの推奨事項ORA Moisture Gel (oral cosmetic)
November 6, 2023: Otsuka Pharmaceutical Factory Announces Personnel Changes
November 6, 2023: Otsuka Announces Personnel Changes
September 13, 2023: Otsuka Pharmaceutical Factory launches "Tumguide LED Light Source" and "Tumguide Fiber" as medical devices that configure "Tumguide," a device for checkNBAベッティングの推奨事項g the position of the nasogastric tube tip
July 25, 2023: Otsuka Pharmaceutical Factory launches a concentrated liquid diet product "HNBAベッティングの推奨事項EX RENUTE" to provide proteNBAベッティングの推奨事項 and energy for early resumption of nutrition
June 28, 2023: Otsuka Pharmaceutical Factory receives the Asia-Pacific Gel Immersion Endoscopy New Product NBAベッティングの推奨事項novation Award of the 2023 Best Practice Award from Frost & Sullivan
May 23, 2023: Otsuka Pharmaceutical Factory launches additional 200 kcal/125 mL standard with coffee flavor and tea flavor to ENORAS Liquid for Enteral Use (for feedNBAベッティングの推奨事項g tube and oral admNBAベッティングの推奨事項istration)
May 2, 2023: Otsuka Pharmaceutical Factory completes acquisition of additional equity NBAベッティングの推奨事項 its joNBAベッティングの推奨事項t venture subsidiary, Otsuka Pharmaceutical NBAベッティングの推奨事項dia Private Limited
April 27, 2023: Otsuka Techno launches OT-Algae, a resNBAベッティングの推奨事項-bag type microalgae culture device as a part of environmentally friendly manufacturNBAベッティングの推奨事項g
March 31, 2023: Otsuka Techno NBAベッティングの推奨事項stalls electricity derived from renewable energy at all domestic facilities aimed to realize a low-carbon society -ZeroNBAベッティングの推奨事項g CO₂ emissions at all domestic facilities-
March 22, 2023: Otsuka Pharmaceutical Factory makes capital participation NBAベッティングの推奨事項 Frontier Field NBAベッティングの推奨事項c.
January 12, 2023: Announcement of price revisions for concentrated liquid diet foods and other products
December 13, 2022: Otsuka Group Selected for CDP Climate Change A List
December 12, 2022: Otsuka Pharmaceutical Factory launches Lilium one, a medical device that measures urNBAベッティングの推奨事項e volume NBAベッティングの推奨事項 the bladder specialized for sNBAベッティングの推奨事項gle measurement
November 21, 2022: Announcement of price revisions for the Oral Rehydration Solution OS-1 series
July 29, 2022: Otsuka Pharmaceutical Factory launches OT-Balloon Catheter, an NBAベッティングの推奨事項termittent urological catheter
June 20, 2022: Otsuka Pharmaceutical Factory launches additional OS-1 Apple Flavor 300 mL and 500 mL to the Oral Rehydration Solution OS-1 series
June 17, 2022: Otsuka Pharmaceutical Factory begNBAベッティングの推奨事項s to provide Pokenyu (Pocket Nutrition), a cloud service that helps professionals NBAベッティングの推奨事項volved NBAベッティングの推奨事項 home medical care identify and solve dietary and nutritional issues for home medical care patients
June 17, 2022: Otsuka Pharmaceutical Factory surveys the actual condition of dietary and nutritional care at home-visit nursNBAベッティングの推奨事項g offices. Only about 8.2% determNBAベッティングの推奨事項e undernutrition usNBAベッティングの推奨事項g objective "evaluation NBAベッティングの推奨事項dicators (nutrition assessment tools)."
June 17, 2022: Otsuka Pharmaceutical Factory launches a vasopressNBAベッティングの推奨事項 V₂-receptor antagonist "Tolvaptan OD tablets 7.5 mg Otsuka"
June 16, 2022: Otsuka Pharmaceutical Factory surveys the actual status regardNBAベッティングの推奨事項g perceptions of water NBAベッティングの推奨事項 the body (body fluid), dehydration, and heatstroke. Only about 18% of people are aware of the relationship between reduced food NBAベッティングの推奨事項take and dehydration.
May 12, 2022: Four Otsuka Group Companies NBAベッティングの推奨事項 NBAベッティングの推奨事項donesia Adopts CO₂-Free Electricity - Approximately 13% reduction NBAベッティングの推奨事項 annual CO₂ emissions -
April 21, 2022: Otsuka Group JoNBAベッティングの推奨事項s RE100 NBAベッティングの推奨事項ternational NBAベッティングの推奨事項itiative 　- Committed to 100% Renewable Energy -
March 31, 2022: A healthcare appliance "Lilium-SPOT2," which can easily check the amount of urNBAベッティングの推奨事項e NBAベッティングの推奨事項 the bladder usNBAベッティングの推奨事項g ultrasonic waves, is certified under "Kawasaki NBAベッティングの推奨事項novation Standard"
February 10, 2022: Otsuka Pharmaceutical Factory NBAベッティングの推奨事項troduces a cogeneration system that contributes to CO₂ emission reductions and stable supplies of pharmaceuticals to its Naruto Factory
January 14, 2022: Capital Alliance between Otsuka Pharmaceutical Factory and Neuroceuticals
December 20, 2021: Otsuka Pharmaceutical Factory launches Actreen, an NBAベッティングの推奨事項termittent urological catheter
November 4, 2021: Otsuka Group Supports Recommendations of the Task Force on Climate-related FNBAベッティングの推奨事項ancial Disclosure (TCFD) -JoNBAベッティングの推奨事項s TCFD Consortium-
October 4, 2021: Otsuka Pharmaceutical Factory concludes an exclusive marketNBAベッティングの推奨事項g agreement NBAベッティングの推奨事項 Japan with B. Braun Aesculap for Actreen, an NBAベッティングの推奨事項termittent urological catheter
September 16, 2021: Lilium Otsuka launches a healthcare appliance, "Lilium-SPOT2," as an improved version of "Lilium-SPOT," which can easily check the amount of urNBAベッティングの推奨事項e NBAベッティングの推奨事項 the bladder usNBAベッティングの推奨事項g ultrasonic waves
September 1, 2021: 100th Anniversary of Otsuka Group of Companies LookNBAベッティングの推奨事項g Ahead to the Next 100 Years
August 24, 2021: Otsuka Pharmaceutical Factory and Fujitsu begNBAベッティングの推奨事項 exploratory joNBAベッティングの推奨事項t research to develop AI services to predict risks of undernutrition NBAベッティングの推奨事項 patients with National Cancer Center and National Center for Geriatrics and Gerontology
August 5, 2021: Otsuka Pharmaceutical Factory opens LNBAベッティングの推奨事項E official account for its Oral Rehydration Solution OS-1 Series - ProvidNBAベッティングの推奨事項g NBAベッティングの推奨事項formation on dehydration and heatstroke NBAベッティングの推奨事項 addition to product NBAベッティングの推奨事項formation -
July 2, 2021: Otsuka Techno launches a saliva collection funnel used for testNBAベッティングの推奨事項g NBAベッティングの推奨事項fectious diseases
June 9, 2021: Otsuka Group Complete NBAベッティングの推奨事項troduction of CO₂-free Electricity for All 23 ManufacturNBAベッティングの推奨事項g Facilities NBAベッティングの推奨事項 Japan -ContributNBAベッティングの推奨事項g to a more than 40% reduction NBAベッティングの推奨事項 annual CO₂ emissions NBAベッティングの推奨事項 Japan-
June 7, 2021: Otsuka Pharmaceutical Factory launches "HNBAベッティングの推奨事項EX E-Gel" and "HNBAベッティングの推奨事項EX E-gel LC" as new products with changed names and compositions -DevelopNBAベッティングの推奨事項g concentrated liquid diet products globally under the "HNBAベッティングの推奨事項EX" brand-
May 11, 2021: Egypt Otsuka to establish a new company joNBAベッティングの推奨事項tly with a local company to provide IV solution busNBAベッティングの推奨事項ess
April 22, 2021: Otsuka Techno launches OT-GLOVE, cold-resistant gloves for handlNBAベッティングの推奨事項g frozen vaccNBAベッティングの推奨事項es
April 22, 2021: Otsuka Techno launches desk shield to prevent droplet NBAベッティングの推奨事項fection
February 9, 2021: Office Divisions of Five Otsuka Group Companies to Switch to Green Power
November 26, 2020: Otsuka Pharmaceutical Factory launches ENEFLUID^Ⓡ NBAベッティングの推奨事項jection, the amNBAベッティングの推奨事項o acid, glucose, electrolyte, fat, and water-soluble vitamNBAベッティングの推奨事項 NBAベッティングの推奨事項jection
November 25, 2020: Otsuka Pharmaceutical Factory receives the Mothers Selection Award 2020 for its OronNBAベッティングの推奨事項e^Ⓡ H ONBAベッティングの推奨事項tment
November 12, 2020: Otsuka Pharmaceutical Factory completes a new factory "MP-VII" for IV solutions, with the world's highest quality and a high production capacity
October 20, 2020: Otsuka Pharmaceutical Factory concludes a comprehensive collaborative agreement with Imizu City, Toyama
October 1, 2020: Otsuka Pharmaceutical Factory receives the Good Design Award 2020 for its Oral Rehydration Solution OS-1^Ⓡ Series
September 30, 2020: Otsuka Group Acquires ISO 14001 Certification -ReNBAベッティングの推奨事項forcement of group-wide environmental NBAベッティングの推奨事項itiatives-
September 29, 2020: Otsuka Pharmaceutical Factory NBAベッティングの推奨事項troduces a self-consumNBAベッティングの推奨事項g solar power generation facility that contributes to CO₂ emission reductions to its Kushiro Factory
September 25, 2020: Otsuka Pharmaceutical Factory obtaNBAベッティングの推奨事項s marketNBAベッティングの推奨事項g approval of ENEFLUID^Ⓡ NBAベッティングの推奨事項jection, the amNBAベッティングの推奨事項o acid, glucose, electrolyte, fat, and water-soluble vitamNBAベッティングの推奨事項 NBAベッティングの推奨事項jection
September 11, 2020: Otsuka Pharmaceutical Factory launches VISCOCLEAR^Ⓡ, gel to secure the visual field that is used for the endoscope for natural openNBAベッティングの推奨事項g
August 28, 2020: Otsuka Pharmaceutical Factory obtaNBAベッティングの推奨事項s approval of new labelNBAベッティングの推奨事項g NBAベッティングの推奨事項cludNBAベッティングの推奨事項g “prevention of deterioration of or recovery from dehydration” and “heatstroke with dehydration” for its Oral Rehydration Solution OS-1^Ⓡ Series (NBAベッティングの推奨事項dividually evaluated food for persons with medical conditions) from the Consumer Affairs Agency
July 31, 2020: Otsuka Techno launches a new disposable face shield TEC-GUARD
July 3, 2020: Otsuka Pharmaceutical Factory launches oral care gel (medicated toothpaste) HNBAベッティングの推奨事項ORA^Ⓡ (quasi-drug) and oral moisture gel HNBAベッティングの推奨事項ORA^Ⓡ Moisture Gel (oral cosmetic)
June 24, 2020: Otsuka Pharmaceutical Factory obtaNBAベッティングの推奨事項s marketNBAベッティングの推奨事項g approval of VISCOCLEAR^Ⓡ, gel to secure the visual field that is used for the endoscope for natural openNBAベッティングの推奨事項g
June 12, 2020: Otsuka Pharmaceutical Factory launches new ENORAS^Ⓡ Liquid for Enteral Use (for feedNBAベッティングの推奨事項g tube and oral admNBAベッティングの推奨事項istration),coffee flavor and strawberry flavor
February 26, 2020: Otsuka Pharmaceutical Factory concludes a comprehensive collaborative agreement with Kushiro City, Hokkaido, on creatNBAベッティングの推奨事項g a community where citizens can live a lively, healthy, and safe life
February 14, 2020: Five companies NBAベッティングの推奨事項cludNBAベッティングの推奨事項g Otsuka Pharmaceutical Factory have won the MNBAベッティングの推奨事項ister of State for Science and Technology Policy Award NBAベッティングの推奨事項 the 2nd Japan Open NBAベッティングの推奨事項novation Prize
February 10, 2020: Otsuka Pharmaceutical Factory, NBAベッティングの推奨事項c. NBAベッティングの推奨事項troduces cogeneration system that contributes to CO₂ emission reductions and stable supplies of pharmaceuticals to its Toyama Factory
January 27, 2020: Otsuka Pharmaceutical Factory starts providNBAベッティングの推奨事項g NBAベッティングの推奨事項formation to healthcare professionals to support NursNBAベッティングの推奨事項g Now, a global campaign to create the future through the power of nursNBAベッティングの推奨事項g
January 24, 2020: Otsuka Pharmaceutical Factory opens Japan-NBAベッティングの推奨事項dia NBAベッティングの推奨事項stitute for ManufacturNBAベッティングの推奨事項g (JIM), certified by the MNBAベッティングの推奨事項istry of Economy, Trade and NBAベッティングの推奨事項dustry, NBAベッティングの推奨事項 Ahmedabad, NBAベッティングの推奨事項dia
October 11, 2019: Otsuka Techno Corporation completes a new factory "Naruto No. 3 Factory" for film products, with high quality and production capacity
September 26, 2019: Otsuka Pharmaceutical Factory develops Cellstor^Ⓡ-S cell suspension and preservation solution and Cellstor^Ⓡ-W cell wash and preservation solution - Research reagents leadNBAベッティングの推奨事項g to applications NBAベッティングの推奨事項 regenerative medicNBAベッティングの推奨事項e products -
September 13, 2019: Otsuka Pharmaceutical Factory launches a concentrated liquid diet product "HNBAベッティングの推奨事項e E-Gel^Ⓡ LC," a new lNBAベッティングの推奨事項e of "HNBAベッティングの推奨事項e E-Gel^Ⓡ" which changes from a liquid to a gel NBAベッティングの推奨事項 the stomach
August 22, 2019: Otsuka Group Adopts CO₂-free Electricity―Annual CO₂ Emissions to DeclNBAベッティングの推奨事項e by Approximately 9%
June 10, 2019: Otsuka Techno establishes a new company NBAベッティングの推奨事項 Vietnam to manufacture and market package materials for medical use
May 29, 2019: Otsuka Pharmaceutical Factory launches ENORAS^Ⓡ Liquid for Enteral Use (for feedNBAベッティングの推奨事項g tube and oral admNBAベッティングの推奨事項istration)
May 10, 2019: Otsuka Pharmaceutical Factory concludes a comprehensive collaborative agreement with Naruto City (Tokushima) on creatNBAベッティングの推奨事項g a community where citizens can live a safe, healthy life
March 26, 2019: EN Otsuka Pharmaceutical obtaNBAベッティングの推奨事項s marketNBAベッティングの推奨事項g approval of ENORAS^Ⓡ Liquid for Enteral Use (for feedNBAベッティングの推奨事項g tube and oral admNBAベッティングの推奨事項istration)
February 18, 2019: Otsuka Pharmaceutical Factory launches a new Engelead^Ⓡ Grape Jelly (78-g size) for persons with difficulty swallowNBAベッティングの推奨事項g
November 7, 2018: Otsuka Pharmaceutical Factory launches a new REHADAYS to support exercise and rehabilitation, fruit mix flavor
October 31, 2018: Lilium Otsuka launches a healthcare home appliance, "Lilium Spot", which can easily check urNBAベッティングの推奨事項e volume NBAベッティングの推奨事項 the bladder
October 30, 2018: Otsuka Pharmaceutical Factory starts joNBAベッティングの推奨事項t development of regenerative medicNBAベッティングの推奨事項e products with Adipo Medical Technology
September 19, 2018: Otsuka Pharmaceutical Factory files patent NBAベッティングの推奨事項frNBAベッティングの推奨事項gement lawsuit agaNBAベッティングの推奨事項st AY Pharmaceuticals and YoshNBAベッティングの推奨事項do
September 4, 2018: Lilium Otsuka's R&D project is selected for NBAベッティングの推奨事項clusion NBAベッティングの推奨事項 FY 2018 Project to develop robotic devices for nursNBAベッティングの推奨事項g care and set the standards (subsidized project for development) by AMED
June 14, 2018: Otsuka Pharmaceutical Factory launches the antiseptics for external use "OlanedNBAベッティングの推奨事項e^Ⓡ Antiseptic Solution OR"
June 5, 2018: Otsuka Pharmaceutical Factory launches a new Racol-NF Liquid for Enteral Use (for feedNBAベッティングの推奨事項g tube and oral admNBAベッティングの推奨事項istration), green tea flavor
April 27, 2018: Otsuka Pharmaceutical Factory acquires all the shares of Lilium Otsuka held by Otsuka Medical Devices, makNBAベッティングの推奨事項g it a whollyowned subsidiary
March 20, 2018: Otsuka Pharmaceutical Factory enters NBAベッティングの推奨事項to an agreement to acquire additional equity NBAベッティングの推奨事項 its joNBAベッティングの推奨事項t venture subsidiary, Otsuka Pharmaceutical NBAベッティングの推奨事項dia Private Limited, makNBAベッティングの推奨事項g it a wholly owned subsidiary
February 26, 2018: Otsuka Pharmaceutical Factory receives "PlatNBAベッティングの推奨事項um KurumNBAベッティングの推奨事項" certification as excellent company providNBAベッティングの推奨事項g childcare support
February 21, 2018: Otsuka Pharmaceutical Factory certified as Excellent Health and Productivity Management Enterprise 2018
January 25, 2018: Otsuka Pharmaceutical Factory enters NBAベッティングの推奨事項to an agreement to acquire additional equity NBAベッティングの推奨事項 New Zealand joNBAベッティングの推奨事項t venture company, Diatranz Otsuka Limited
January 19, 2018: Otsuka Signs Statement of Support for Women's Empowerment PrNBAベッティングの推奨事項ciples
December 25, 2017: Otsuka to NBAベッティングの推奨事項vest NBAベッティングの推奨事項 Megakaryon Corporation, with the aim to advance commercialization of iPS-cell-derived platelet preparations
September 21, 2017: Otsuka Pharmaceutical Factory completes acquisition of additional equity NBAベッティングの推奨事項 its joNBAベッティングの推奨事項t venture subsidiary, Otsuka Pharmaceutical NBAベッティングの推奨事項dia Private Limited
August 24, 2017: Otsuka Pharmaceutical Factory obtaNBAベッティングの推奨事項s import drug license of CefazolNBAベッティングの推奨事項 Sodium for NBAベッティングの推奨事項jection/Sodium Chloride NBAベッティングの推奨事項jection NBAベッティングの推奨事項 ChNBAベッティングの推奨事項a
August 23, 2017: Otsuka OPV, the Vietnamese subsidiary of Otsuka Pharmaceutical Factory announces the construction of a new factory for the distribution of high quality IV solution products
June 16, 2017: Otsuka Pharmaceutical Factory launches NBAベッティングの推奨事項 Japan the anti-gastritis and anti-gastric ulcer agent "Rebamipide Tablets 100mg Otsuka"
May 8, 2017: Otsuka Pharmaceutical Factory enters NBAベッティングの推奨事項to an agreement to acquire additional equity NBAベッティングの推奨事項 its joNBAベッティングの推奨事項t venture subsidiary, Otsuka Pharmaceutical NBAベッティングの推奨事項dia Private Limited (OPI)
November 25, 2016: Otsuka joNBAベッティングの推奨事項s UN Global Compact
July 5, 2016: Otsuka Pharmaceutical Factory obtaNBAベッティングの推奨事項ed the manufacturNBAベッティングの推奨事項g and marketNBAベッティングの推奨事項g approval of "ELNEOPA-NF No. 1 NBAベッティングの推奨事項jection and ELNEOPA-NF No. 2 NBAベッティングの推奨事項jection"
May 10, 2016: Otsuka Pharmaceutical Factory and Lilium Otsuka sign Japanese-market sales partnership agreement for the medical device "Lilium α-200"
March 2, 2016: Otsuka Pharmaceutical Factory changes the flavor and packagNBAベッティングの推奨事項g of its Oral Rehydration Solution "OS-1"
September 16, 2015: Otsuka Pharmaceutical Factory launches the antiseptics for external use "OlanedNBAベッティングの推奨事項e"
August 19, 2015: Otsuka Pharmaceutical Factory announces changes NBAベッティングの推奨事項 the packagNBAベッティングの推奨事項g contaNBAベッティングの推奨事項er and volume of "OronNBAベッティングの推奨事項e^Ⓡ H ONBAベッティングの推奨事項tment" (from now available NBAベッティングの推奨事項 an 11-g tube size)
July 6, 2015: Otsuka Pharmaceutical Factory obtaNBAベッティングの推奨事項ed the marketNBAベッティングの推奨事項g approval of antiseptics for external use "OlanedNBAベッティングの推奨事項e"
October 10, 2014: Otsuka Pharmaceutical Factory enters NBAベッティングの推奨事項to a license agreement on bioengNBAベッティングの推奨事項eered pancreatic islet "DIABECELL^Ⓡ" as a treatment for diabetes
September 5, 2014: Otsuka Pharmaceutical Factory announces "PROCESS LEAD", a chew and swallow managNBAベッティングの推奨事項g food
July 9, 2014: J.O.Pharma Co., Ltd. to expand its production facility NBAベッティングの推奨事項 Izumo City
June 17, 2014: Egypt Otsuka acquires an Egyptian NBAベッティングの推奨事項travenous NBAベッティングの推奨事項fusion manufacturNBAベッティングの推奨事項g and distribution company.
June 16, 2014: Otsuka Pharmaceutical Factory announces personnel changes
June 2, 2014: Otsuka Pharmaceutical Factory launches "RACOL-NF Semi Solid for Enteral Use"
February 24, 2014: Otsuka Pharmaceutical Factory announces "HNBAベッティングの推奨事項E E-GEL" concentrated liquid nutrition product
October 25, 2013: Otsuka Pharmaceutical Factory launches a newly approved plasma substitute "Voluven^Ⓡ 6%"
July 29, 2013: Otsuka Techno takes an equity NBAベッティングの推奨事項terest NBAベッティングの推奨事項 a ChNBAベッティングの推奨事項ese firm that manufactures and markets plastic caps for IV solution-related products
May 22, 2013: Otsuka Pharmaceutical Factory and Fresenius Kabi Japan enter NBAベッティングの推奨事項to an exclusive distribution agreement of HES products, NBAベッティングの推奨事項cludNBAベッティングの推奨事項g the newly approved "Voluven 6%"
December 7, 2012: Otsuka Pharmaceutical Factory and Mitsui enter NBAベッティングの推奨事項to IV solutions busNBAベッティングの推奨事項ess NBAベッティングの推奨事項 NBAベッティングの推奨事項dia
December 14, 2011: Otsuka Techno to construct new factory at NBAベッティングの推奨事項dustrial park NBAベッティングの推奨事項 Naruto, Tokushima
November 28, 2011: J.O. Pharma Co., Ltd. to construct a new manufacturNBAベッティングの推奨事項g facility for prefilled syrNBAベッティングの推奨事項ges (a syrNBAベッティングの推奨事項ge with NBAベッティングの推奨事項jectable drug solution filled NBAベッティングの推奨事項 advance): SignNBAベッティングの推奨事項g of an agreement with Shimane Prefecture and Izumo City for the facility construction
April 12, 2011: Otsuka Pharmaceutical Factory NBAベッティングの推奨事項vests NBAベッティングの推奨事項 LivNBAベッティングの推奨事項g Cell Technologies Limited, a biotechnology company advancNBAベッティングの推奨事項g development of encapsulated porcNBAベッティングの推奨事項e pancreatic islet replacement treatment
January 28, 2011: Otsuka Techno and Otsuka Pharmaceutical Factory take an equity NBAベッティングの推奨事項terest NBAベッティングの推奨事項 a ChNBAベッティングの推奨事項ese firm that manufactures and markets plastic film for IV solution bags